Cancer genomics: conducting exemplary trials with biospecimen and biomarker components.
Translating research on genomic changes into novel interventions for patients with cancer requires increased analysis of biospecimens and biomarkers in cancer clinical trials, which involve certain procedural requirements.
Baer
Allison R
AR
American Society of Clinical Oncology, Alexandria, VA; Patient Advocates in Research, Danville, CA; Research Advocacy Network, Plano, TX; and Sarah Cannon Research Institute, Nashville, TN.
Collyar
Deborah
D
Smith
Mary Lou
ML
Bendell
Johanna
J
N Engl J Med. 2005 Oct 20;353(16):1673-84
16236738
J Clin Oncol. 2006 Jun 20;24(18):2707-14
16782910
J Clin Oncol. 2008 May 20;26(15):2562-7
18390967
N Engl J Med. 2009 Apr 2;360(14):1408-17
19339720